Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Bezieau, S; Devilder, MC; Avet-Loiseau, H; Mellerin, MP; Puthier, D; Pennarun, E; Rapp, MJ; Harousseau, JL; Moisan, JP; Bataille, R
   High incidence of N and K-Ras activating mutations in multiple myeloma andprimary plasma cell leukemia at diagnosis
   HUMAN MUTATION
   
   S. Bezieau et al., "High incidence of N and K-Ras activating mutations in multiple myeloma andprimary plasma cell leukemia at diagnosis", HUM MUTAT, 18(3), 2001, pp. 212-224
2. Christou, L; Hatzimichael, E; Chaidos, A; Tsiara, S; Bourantas, KL
   Treatment of plasma cell leukemia with vincristine, liposomal doxorubicin and dexamethasone
   EUROPEAN JOURNAL OF HAEMATOLOGY
   
   L. Christou et al., "Treatment of plasma cell leukemia with vincristine, liposomal doxorubicin and dexamethasone", EUR J HAEMA, 67(1), 2001, pp. 51-53
3. Fonseca, R; Oken, MM; Harrington, D; Bailey, RJ; Van Wier, SA; Henderson, KJ; Kay, NE; Van Ness, B; Greipp, PR; Dewald, GW
   Deletions of chromosome 13 in multiple myeloma identified by interphase FISH usually denote large deletions of the q arm or monosomy
   LEUKEMIA
   
   R. Fonseca et al., "Deletions of chromosome 13 in multiple myeloma identified by interphase FISH usually denote large deletions of the q arm or monosomy", LEUKEMIA, 15(6), 2001, pp. 981-986
4. Gutierrez, NC; Hernandez, JM; Garcia, JL; Canizo, MC; Gonzalez, M; Hernandez, J; Gonzalez, MB; Garcia-Marcos, MA; San Miguel, JF
   Differences in genetic changes between multiple myeloma and plasma cell leukemia demonstrated by comparative genomic hybridization
   LEUKEMIA
   
   N.C. Gutierrez et al., "Differences in genetic changes between multiple myeloma and plasma cell leukemia demonstrated by comparative genomic hybridization", LEUKEMIA, 15(5), 2001, pp. 840-845
5. Mokeeva, RA; Abakumov, EM; Dyagileva, OA; Shishkanova, ZG; Samoilova, RS; Roschina, LS; Biryukova, LS
   On so-called plasmocytic leukemia with systemic polyorganic specific lesion.
   GEMATOLOGIYA I TRANSFUZIOLOGIYA
   
   R.A. Mokeeva et al., "On so-called plasmocytic leukemia with systemic polyorganic specific lesion.", GEMATOL TR, 46(2), 2001, pp. 14-21
6. Ng, MHL; Wong, N; Tsang, KS; Cheng, SH; Chung, YF; Lo, KW
   Recurrent chromosomal rearrangements involving breakpoints 3p21 and 19q13 in Chinese IgD multiple myeloma detected by G-banding and multicolor spectral karyotyping: A review of IgD karyotype literature
   HUMAN PATHOLOGY
   
   M.H.L. Ng et al., "Recurrent chromosomal rearrangements involving breakpoints 3p21 and 19q13 in Chinese IgD multiple myeloma detected by G-banding and multicolor spectral karyotyping: A review of IgD karyotype literature", HUMAN PATH, 32(9), 2001, pp. 1016-1020
7. Smadja, NV; Bastard, C; Brigaudeau, C; Leroux, D; Fruchart, C
   Hypodiploidy is a major prognostic factor in multiple myeloma
   BLOOD
   
   N.V. Smadja et al., "Hypodiploidy is a major prognostic factor in multiple myeloma", BLOOD, 98(7), 2001, pp. 2229-2238
8. Ho, PJ; Brown, RD; Pelka, GJ; Basten, A; Gibson, J; Joshua, DE
   Illegitimate switch recombinations are present in approximately half of primary myeloma tumors, but do not relate to known prognostic indicators or survival
   BLOOD
   
   P.J. Ho et al., "Illegitimate switch recombinations are present in approximately half of primary myeloma tumors, but do not relate to known prognostic indicators or survival", BLOOD, 97(2), 2001, pp. 490-495
9. O'Quinn, K
   Pathologic quiz case - A 43-year-old man with fatigue and night sweats
   ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
   
   K. O'Quinn, "Pathologic quiz case - A 43-year-old man with fatigue and night sweats", ARCH PATH L, 125(6), 2001, pp. 838-840
10. Colombi, M; Guffanti, A; Alietti, A; Latargia, ML; Vener, C; Maiolo, AT; Baldini, L
    OPP-EBV-CAD regimen as salvage treatment in advanced refractory or resistant multiple myeloma
    LEUKEMIA & LYMPHOMA
    
    M. Colombi et al., "OPP-EBV-CAD regimen as salvage treatment in advanced refractory or resistant multiple myeloma", LEUK LYMPH, 40(1-2), 2000, pp. 87-94
11. Kastrinakis, NG; Gorgoulis, VG; Foukas, PG; Dimopoulos, MA; Kittas, C
    Molecular aspects of multiple myeloma
    ANNALS OF ONCOLOGY
    
    N.G. Kastrinakis et al., "Molecular aspects of multiple myeloma", ANN ONCOL, 11(10), 2000, pp. 1217-1228
12. Davies, FE; Anderson, KC
    Novel therapeutic targets in multiple myeloma
    EUROPEAN JOURNAL OF HAEMATOLOGY
    
    F.E. Davies e K.C. Anderson, "Novel therapeutic targets in multiple myeloma", EUR J HAEMA, 64(6), 2000, pp. 359-367
13. Gonzalez, M; Mateos, MV; Garcia-Sanz, R; Balanzategui, A; Lopez-Perez, R; Chillon, MC; Gonzalez, D; Alaejos, I; San Miguel, JF
    De novo methylation of tumor suppressor gene p16/INK4a is a frequent finding in multiple myeloma patients at diagnosis
    LEUKEMIA
    
    M. Gonzalez et al., "De novo methylation of tumor suppressor gene p16/INK4a is a frequent finding in multiple myeloma patients at diagnosis", LEUKEMIA, 14(1), 2000, pp. 183-187
14. Drach, J; Kaufmann, H; Urbauer, E; Schreiber, S; Ackermann, J; Huber, H
    The biology of multiple myeloma
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
    
    J. Drach et al., "The biology of multiple myeloma", J CANC RES, 126(8), 2000, pp. 441-447
15. Drexler, HG; Matsuo, Y
    Malignant hematopoietic cell lines: in vitro models for the study of multiple myeloma and plasma cell leukemia
    LEUKEMIA RESEARCH
    
    H.G. Drexler e Y. Matsuo, "Malignant hematopoietic cell lines: in vitro models for the study of multiple myeloma and plasma cell leukemia", LEUK RES, 24(8), 2000, pp. 681-703
16. Shou, YP; Martelli, ML; Gabrea, A; Qi, Y; Brents, LA; Roschke, A; Dewald, G; Kirsch, IR; Bergsagel, PL; Kuehl, WM
    Diverse karyotypic abnormalities of the c-myc locus associated with c-myc dysregulation and tumor progression in multiple myeloma
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    
    Y.P. Shou et al., "Diverse karyotypic abnormalities of the c-myc locus associated with c-myc dysregulation and tumor progression in multiple myeloma", P NAS US, 97(1), 2000, pp. 228-233
17. Hoechtlen-Vollmar, W; Menzel, G; Bartl, R; Lamerz, R; Wick, M; Seidel, D
    Amplification of cyclin D1 gene in multiple myeloma: Clinical and prognostic relevance
    BRITISH JOURNAL OF HAEMATOLOGY
    
    W. Hoechtlen-Vollmar et al., "Amplification of cyclin D1 gene in multiple myeloma: Clinical and prognostic relevance", BR J HAEM, 109(1), 2000, pp. 30-38
18. Szczepanski, T; van't Veer, MB; Wolvers-Tettero, ILM; Langerak, AW; van Dongen, JJM
    Molecular features responsible for the absence of immunoglobulin heavy chain protein synthesis in an IgH(-) subgroup of multiple myeloma
    BLOOD
    
    T. Szczepanski et al., "Molecular features responsible for the absence of immunoglobulin heavy chain protein synthesis in an IgH(-) subgroup of multiple myeloma", BLOOD, 96(3), 2000, pp. 1087-1093
19. Desikan, R; Barlogie, D; Sawyer, J; Ayers, D; Tricot, G; Badros, A; Zangari, M; Munshi, NC; Anaissle, E; Spoon, D; Siegel, D; Jagannath, S; Vesole, D; Epstein, J; Shaughnessy, J; Fassas, A; Lim, S; Roberson, P; Crowley, J
    Results of high-dose therapy for 1000 patients with multiple myeloma: durable complete remissions and superior survival in the absence of chromosome 13 abnormalities
    BLOOD
    
    R. Desikan et al., "Results of high-dose therapy for 1000 patients with multiple myeloma: durable complete remissions and superior survival in the absence of chromosome 13 abnormalities", BLOOD, 95(12), 2000, pp. 4008-4010
20. AVETLOISEAU H; BRIGAUDEAU C; MORINEAU N; TALMANT P; LAI JL; DAVIET A; LI JY; PRALORAN V; RAPP MJ; HAROUSSEAU JL; FACON T; BATAILLE R
    HIGH-INCIDENCE OF CRYPTIC TRANSLOCATIONS INVOLVING THE IG HEAVY-CHAINGENE IN MULTIPLE-MYELOMA, AS SHOWN BY FLUORESCENCE IN-SITU HYBRIDIZATION
    Genes chromosomes & cancer (Print)
    
    H. Avetloiseau et al., "HIGH-INCIDENCE OF CRYPTIC TRANSLOCATIONS INVOLVING THE IG HEAVY-CHAINGENE IN MULTIPLE-MYELOMA, AS SHOWN BY FLUORESCENCE IN-SITU HYBRIDIZATION", Genes chromosomes & cancer (Print), 24(1), 1999, pp. 9-15
21. Fonseca, R; Hoyer, JD; Aguayo, P; Jalal, SM; Ahmann, GJ; Rajkumar, SV; Witzig, TE; Lacy, MQ; Dispenzieri, A; Gertz, MA; Kyle, RA; Greipp, PR
    Clinical significance of the translocation (11;14)(q13;q32) in multiple myeloma
    LEUKEMIA & LYMPHOMA
    
    R. Fonseca et al., "Clinical significance of the translocation (11;14)(q13;q32) in multiple myeloma", LEUK LYMPH, 35(5-6), 1999, pp. 599-605
22. Greipp, PR; Trendle, MC; Leong, T; Oken, MM; Kay, NE; Van Ness, B; Kyle, RA
    Is flow cytometric DNA content hypodiploidy prognostic in multiple myeloma?
    LEUKEMIA & LYMPHOMA
    
    P.R. Greipp et al., "Is flow cytometric DNA content hypodiploidy prognostic in multiple myeloma?", LEUK LYMPH, 35(1-2), 1999, pp. 83-89
23. Kikuchi, M; Ohsaka, A; Chiba, Y; Sato, M; Muraosa, Y; Hoshino, H
    Bone marrow aplasia with prominent atypical plasmacytic proliferation preceding acute lymphoblastic leukemia
    LEUKEMIA & LYMPHOMA
    
    M. Kikuchi et al., "Bone marrow aplasia with prominent atypical plasmacytic proliferation preceding acute lymphoblastic leukemia", LEUK LYMPH, 35(1-2), 1999, pp. 213-217
24. Kawada, E; Shinonome, S; Saitoh, T; Tamura, J; Karasawa, M; Sawamura, M; Murakami, H
    Primary nonsecretory plasma cell leukemia: a rare variant of multiple myeloma
    ANNALS OF HEMATOLOGY
    
    E. Kawada et al., "Primary nonsecretory plasma cell leukemia: a rare variant of multiple myeloma", ANN HEMATOL, 78(1), 1999, pp. 25-27
25. Fonseca, R; Coignet, LJA; Dewald, GW
    Cytogenetic abnormalities in multiple myeloma
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
    
    R. Fonseca et al., "Cytogenetic abnormalities in multiple myeloma", HEMAT ONCOL, 13(6), 1999, pp. 1169
26. Proffitt, J; Fenton, J; Pratt, G; Yates, Z; Morgan, G
    Isolation and characterisation of recombination events involving immunoglobulin heavy chain switch regions in multiple myeloma using long distance vectorette PCR (LDV-PCR)
    LEUKEMIA
    
    J. Proffitt et al., "Isolation and characterisation of recombination events involving immunoglobulin heavy chain switch regions in multiple myeloma using long distance vectorette PCR (LDV-PCR)", LEUKEMIA, 13(7), 1999, pp. 1100-1107
27. Hjorth-Hansen, H; Seifert, MF; Borset, M; Aarset, H; Ostlie, A; Sundan, A; Waage, A
    Marked osteoblastopenia and reduced bone formation in a model of multiple myeloma bone disease in severe combined immunodeficiency mice
    JOURNAL OF BONE AND MINERAL RESEARCH
    
    H. Hjorth-Hansen et al., "Marked osteoblastopenia and reduced bone formation in a model of multiple myeloma bone disease in severe combined immunodeficiency mice", J BONE MIN, 14(2), 1999, pp. 256-263
28. Lloveras, E; Sole, F; Espinet, B; Florensa, L; Vazquez, A; Woessner, S
    May-Grunwald-Giemsa fluorescence in situ hybridization technique applied to a plasma cell leukemia
    HAEMATOLOGICA
    
    E. Lloveras et al., "May-Grunwald-Giemsa fluorescence in situ hybridization technique applied to a plasma cell leukemia", HAEMATOLOG, 84(6), 1999, pp. 568-569
29. Maslovsky, I; Lugassy, G; Blumental, R; Ducach, A; Yehuda, O; Abeliovich, D
    Multiple chromosomal abnormalities in fulminant anaplastic myeloma
    CLINICAL AND LABORATORY HAEMATOLOGY
    
    I. Maslovsky et al., "Multiple chromosomal abnormalities in fulminant anaplastic myeloma", CLIN LAB H, 21(3), 1999, pp. 207-210
30. Avet-Loiseau, H; Facon, T; Daviet, A; Godon, C; Rapp, MJ; Harousseau, JL; Grosbois, B; Bataille, R
    14q32 translocations and monosomy 13 observed in monoclonal gammopathy of undetermined significance delineate a multistep process for the oncogenesisof multiple myeloma
    CANCER RESEARCH
    
    H. Avet-Loiseau et al., "14q32 translocations and monosomy 13 observed in monoclonal gammopathy of undetermined significance delineate a multistep process for the oncogenesisof multiple myeloma", CANCER RES, 59(18), 1999, pp. 4546-4550
31. Avet-Loiseau, H; Li, JY; Morineau, N; Facon, T; Brigaudeau, C; Harousseau, JL; Grosbois, B; Bataille, R
    Monosomy 13 is associated with the transition of monoclonal gammopathy of undetermined significance to multiple myeloma
    BLOOD
    
    H. Avet-Loiseau et al., "Monosomy 13 is associated with the transition of monoclonal gammopathy of undetermined significance to multiple myeloma", BLOOD, 94(8), 1999, pp. 2583-2589
32. Finelli, P; Fabris, S; Zagano, S; Baldini, L; Intini, D; Nobili, L; Lombardi, L; Maiolo, AT; Neri, A
    Detection of t(4;14)(p16.3;q32) chromosomal translocation in multiple myeloma by double-color fluorescent in situ hybridization
    BLOOD
    
    P. Finelli et al., "Detection of t(4;14)(p16.3;q32) chromosomal translocation in multiple myeloma by double-color fluorescent in situ hybridization", BLOOD, 94(2), 1999, pp. 724-732
33. Panizo, C; Rifon, J; Rodriguez-Wilhelmi, P; Cuesta, B; Rocha, E
    Long-term survival in primary plasma cell leukemia after therapy with VAD,autologous blood stem cell transplantation and interferon-alpha
    ACTA HAEMATOLOGICA
    
    C. Panizo et al., "Long-term survival in primary plasma cell leukemia after therapy with VAD,autologous blood stem cell transplantation and interferon-alpha", ACT HAEMAT, 101(4), 1999, pp. 193-196
34. Sonoki, T; Matsuzaki, H; Satterwhite, E; Nakazawa, N; Hata, H; Tucker, PW; Taniwaki, M; Kuribayashi, N; Harada, N; Matsuno, F; Mitsuya, H
    A plasma cell leukemia patient showing bialleic 14q translocations: t(2;14) and t(11;14)
    ACTA HAEMATOLOGICA
    
    T. Sonoki et al., "A plasma cell leukemia patient showing bialleic 14q translocations: t(2;14) and t(11;14)", ACT HAEMAT, 101(4), 1999, pp. 197-201
35. SMADJA NV; FRUCHART C; ISNARD F; LOUVET C; DUTEL JL; CHERON N; GRANGE MJ; MONCONDUIT M; BASTARD C
    CHROMOSOMAL ANALYSIS IN MULTIPLE-MYELOMA - CYTOGENETIC EVIDENCE OF 2 DIFFERENT DISEASES
    Leukemia
    
    N.V. Smadja et al., "CHROMOSOMAL ANALYSIS IN MULTIPLE-MYELOMA - CYTOGENETIC EVIDENCE OF 2 DIFFERENT DISEASES", Leukemia, 12(6), 1998, pp. 960-969
36. Pellat-Deceunynck, C; Barille, S; Jego, G; Puthier, D; Robillard, N; Pineau, D; Rapp, MJ; Harousseau, JL; Amiot, M; Bataille, R
    The absence of CD56 (NCAM) on malignant plasma cells is a hallmark of plasma cell leukemia and of a special subset of multiple myeloma
    LEUKEMIA
    
    C. Pellat-Deceunynck et al., "The absence of CD56 (NCAM) on malignant plasma cells is a hallmark of plasma cell leukemia and of a special subset of multiple myeloma", LEUKEMIA, 12(12), 1998, pp. 1977-1982
37. KURIBAYASHI N; MATSUZAKI H; HATA H; YOSHIDA M; SONOKI T; NAGASAKI A; KIMURA T; OKAMOTO K; KUROSE M; TSUDA H; TAKATSUKI K
    MULTIPLE-MYELOMA ASSOCIATED WITH SERUM AMINO-ACID DISTURBANCE AND HIGH-OUTPUT CARDIAC-FAILURE
    American journal of hematology
    
    N. Kuribayashi et al., "MULTIPLE-MYELOMA ASSOCIATED WITH SERUM AMINO-ACID DISTURBANCE AND HIGH-OUTPUT CARDIAC-FAILURE", American journal of hematology, 57(1), 1998, pp. 77-81
38. SICA S; CHIUSOLO P; SALUTARI P; PICCIRILLO N; LAURENTI L; LABARBERA EO; SERRA FG; LEONE G
    LONG-LASTING COMPLETE REMISSION IN PLASMA-CELL LEUKEMIA AFTER AGGRESSIVE CHEMOTHERAPY AND CD34-SELECTED AUTOLOGOUS PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANT - MOLECULAR FOLLOW-UP OF MINIMAL RESIDUAL DISEASE
    Bone marrow transplantation
    
    S. Sica et al., "LONG-LASTING COMPLETE REMISSION IN PLASMA-CELL LEUKEMIA AFTER AGGRESSIVE CHEMOTHERAPY AND CD34-SELECTED AUTOLOGOUS PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANT - MOLECULAR FOLLOW-UP OF MINIMAL RESIDUAL DISEASE", Bone marrow transplantation, 22(8), 1998, pp. 823-825
39. LAI JL; MICHAUX L; DASTUGUE N; VASSEUR F; DAUDIGNON A; FACON T; BAUTERS F; ZANDECKI M
    CYTOGENETICS IN MULTIPLE-MYELOMA - A MULTICENTER STUDY OF 24 PATIENTSWITH T(11-14)(Q13-Q32) OR ITS VARIANT
    Cancer genetics and cytogenetics
    
    J.L. Lai et al., "CYTOGENETICS IN MULTIPLE-MYELOMA - A MULTICENTER STUDY OF 24 PATIENTSWITH T(11-14)(Q13-Q32) OR ITS VARIANT", Cancer genetics and cytogenetics, 104(2), 1998, pp. 133-138
40. ALONSO ML; RUBIOL E; MATEU R; ESTIVILL C; BELLIDO M; BALMANA J; NOMDEDEU JF
    CCD79A EXPRESSION IN A CASE OF PLASMA-CELL LEUKEMIA
    Leukemia research
    
    M.L. Alonso et al., "CCD79A EXPRESSION IN A CASE OF PLASMA-CELL LEUKEMIA", Leukemia research, 22(7), 1998, pp. 649-653
41. SEONG C; DELASALLE K; HAYES K; WEBER D; DIMOPOULOS M; SWANTKOWSKI J; HUH Y; GLASSMAN A; CHAMPLIN R; ALEXANIAN R
    PROGNOSTIC VALUE OF CYTOGENETICS IN MULTIPLE-MYELOMA
    British Journal of Haematology
    
    C. Seong et al., "PROGNOSTIC VALUE OF CYTOGENETICS IN MULTIPLE-MYELOMA", British Journal of Haematology, 101(1), 1998, pp. 189-194
42. Fonseca, R; Ahmann, GJ; Jalal, SM; Dewald, GW; Larson, DR; Therneau, TM; Gertz, MA; Kyle, RA; Greipp, PR
    Chromosomal abnormalities in systemic amyloidosis
    BRITISH JOURNAL OF HAEMATOLOGY
    
    R. Fonseca et al., "Chromosomal abnormalities in systemic amyloidosis", BR J HAEM, 103(3), 1998, pp. 704-710
43. SAWYER JR; LUKACS JL; MUNSHI N; DESIKAN KR; SINGHAL S; MEHTA J; SIEGEL D; SHAUGHNESSY J; BARLOGIE B
    IDENTIFICATION OF NEW NONRANDOM TRANSLOCATIONS IN MULTIPLE-MYELOMA WITH MULTICOLOR SPECTRAL KARYOTYPING
    Blood
    
    J.R. Sawyer et al., "IDENTIFICATION OF NEW NONRANDOM TRANSLOCATIONS IN MULTIPLE-MYELOMA WITH MULTICOLOR SPECTRAL KARYOTYPING", Blood, 92(11), 1998, pp. 4269-4278
44. IIDA S; RAO PH; BUTLER M; CORRADINI P; BOCCADORO M; KLEIN B; CHAGANTI RSK; DALLAFAVERA R
    DEREGULATION OF MUM1 IRF4 BY CHROMOSOMAL TRANSLOCATION IN MULTIPLE-MYELOMA/
    Nature genetics
    
    S. Iida et al., "DEREGULATION OF MUM1 IRF4 BY CHROMOSOMAL TRANSLOCATION IN MULTIPLE-MYELOMA/", Nature genetics, 17(2), 1997, pp. 226-230
45. CALASANZ MJ; CIGUDOSA JC; ODERO MD; FERREIRA C; ARDANAZ MT; FRAILE A; CARRASCO JL; SOLE F; CUESTA B; GULLON A
    CYTOGENETIC ANALYSIS OF 280 PATIENTS WITH MULTIPLE-MYELOMA AND RELATED DISORDERS - PRIMARY BREAKPOINTS AND CLINICAL CORRELATIONS
    Genes, chromosomes & cancer
    
    M.J. Calasanz et al., "CYTOGENETIC ANALYSIS OF 280 PATIENTS WITH MULTIPLE-MYELOMA AND RELATED DISORDERS - PRIMARY BREAKPOINTS AND CLINICAL CORRELATIONS", Genes, chromosomes & cancer, 18(2), 1997, pp. 84-93
46. SHIMAZAKI C; GOTO H; ARAKI S; TATSUMI T; TAKAHASHI R; HIRAI H; KIKUTA T; YAMAGATA N; ASHIHARA E; INABA T; FUJITA N; SUZUKI R; NAKAGAWA M
    OVEREXPRESSION OF PRAD1 CYCLIN D1 IN PLASMA-CELL LEUKEMIA WITH T(11-14)(Q13-Q32)
    International journal of hematology
    
    C. Shimazaki et al., "OVEREXPRESSION OF PRAD1 CYCLIN D1 IN PLASMA-CELL LEUKEMIA WITH T(11-14)(Q13-Q32)", International journal of hematology, 66(1), 1997, pp. 111-115
47. NISHIMOTO N; SHIMA Y; YOSHIZAKI K; KISHIMOTO T
    MYELOMA BIOLOGY AND THERAPY - PRESENT STATUS AND FUTURE-DEVELOPMENTS
    Hematology/oncology clinics of North America
    
    N. Nishimoto et al., "MYELOMA BIOLOGY AND THERAPY - PRESENT STATUS AND FUTURE-DEVELOPMENTS", Hematology/oncology clinics of North America, 11(1), 1997, pp. 159
48. PASQUALETTI P; CASALE R
    MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE EVOLVING DIRECTLY IN PRIMARY PLASMA-CELL LEUKEMIA
    Biomedicine & pharmacotherapy
    
    P. Pasqualetti e R. Casale, "MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE EVOLVING DIRECTLY IN PRIMARY PLASMA-CELL LEUKEMIA", Biomedicine & pharmacotherapy, 51(6-7), 1997, pp. 284-285
49. MICHAELI J; CHOY CG; ZHANG XJ
    THE BIOLOGICAL FEATURES OF MULTIPLE-MYELOMA
    Cancer investigation
    
    J. Michaeli et al., "THE BIOLOGICAL FEATURES OF MULTIPLE-MYELOMA", Cancer investigation, 15(1), 1997, pp. 76-84
50. HOVENGA S; DEWOLF JTM; KLIP H; VELLENGA E
    CONSOLIDATION THERAPY WITH AUTOLOGOUS STEM-CELL TRANSPLANTATION IN PLASMA-CELL LEUKEMIA AFTER VAD, HIGH-DOSE CYCLOPHOSPHAMIDE AND EDAP COURSES - A REPORT OF 3 CASES AND A REVIEW OF THE LITERATURE
    Bone marrow transplantation
    
    S. Hovenga et al., "CONSOLIDATION THERAPY WITH AUTOLOGOUS STEM-CELL TRANSPLANTATION IN PLASMA-CELL LEUKEMIA AFTER VAD, HIGH-DOSE CYCLOPHOSPHAMIDE AND EDAP COURSES - A REPORT OF 3 CASES AND A REVIEW OF THE LITERATURE", Bone marrow transplantation, 20(10), 1997, pp. 901-904
51. PIZZUTI P; PERTUISET E; CHAUMONNOT F; CHESNEAU A; MIKOL J; LEBLONDMISSENARD V; FERMAND JP
    MENINGEAL AND CEREBRAL INVOLVEMENT IN MUL TIPLE-MYELOMA - 3 NEW CASESAND REVIEW OF THE LITERATURE
    La Revue de medecine interne
    
    P. Pizzuti et al., "MENINGEAL AND CEREBRAL INVOLVEMENT IN MUL TIPLE-MYELOMA - 3 NEW CASESAND REVIEW OF THE LITERATURE", La Revue de medecine interne, 18(8), 1997, pp. 646-651
52. SANTOS CP; PALOMERO BC; ABINZANO MC; ROCA JR; HERNANDO ER
    CLINICAL AND EVOLUTIVE STUDY OF PLASMA-CE LL LEUKEMIA - REPORT OF 9 CASES
    Revista Clinica Espanola
    
    C.P. Santos et al., "CLINICAL AND EVOLUTIVE STUDY OF PLASMA-CE LL LEUKEMIA - REPORT OF 9 CASES", Revista Clinica Espanola, 197(5), 1997, pp. 341-345
53. CALASANZ MJ; CIGUDOSA JC; ODERO MD; GARCIAFONCILLAS J; MARIN J; ARDANAZ MT; ROCHA E; GULLON A
    HYPODIPLOIDY AND 22Q11 REARRANGEMENTS AT DIAGNOSIS ARE ASSOCIATED WITH POOR-PROGNOSIS IN PATIENTS WITH MULTIPLE-MYELOMA
    British Journal of Haematology
    
    M.J. Calasanz et al., "HYPODIPLOIDY AND 22Q11 REARRANGEMENTS AT DIAGNOSIS ARE ASSOCIATED WITH POOR-PROGNOSIS IN PATIENTS WITH MULTIPLE-MYELOMA", British Journal of Haematology, 98(2), 1997, pp. 418-425
54. BRIGAUDEAU C; TRIMOREAU F; GACHARD N; ROUZIER E; JACCARD A; BORDESSOULE D; PRALORAN V
    CYTOGENETIC STUDY OF 30 PATIENTS WITH MULTIPLE-MYELOMA - COMPARISON OF 3 AND 6 DAY BONE-MARROW CULTURES STIMULATED OR NOT WITH CYTOKINES BYUSING A MINIATURIZED KARYOTYPIC METHOD
    British Journal of Haematology
    
    C. Brigaudeau et al., "CYTOGENETIC STUDY OF 30 PATIENTS WITH MULTIPLE-MYELOMA - COMPARISON OF 3 AND 6 DAY BONE-MARROW CULTURES STIMULATED OR NOT WITH CYTOKINES BYUSING A MINIATURIZED KARYOTYPIC METHOD", British Journal of Haematology, 96(3), 1997, pp. 594-600
55. TASAKA T; BERENSON J; VESCIO R; HIRAMA T; MILLER CW; NAGAI M; TAKAHARA J; KOEFFLER HP
    ANALYSIS OF THE P16(INK4A), P15(INK4B) AND P18(INK4C) GENES IN MULTIPLE-MYELOMA
    British Journal of Haematology
    
    T. Tasaka et al., "ANALYSIS OF THE P16(INK4A), P15(INK4B) AND P18(INK4C) GENES IN MULTIPLE-MYELOMA", British Journal of Haematology, 96(1), 1997, pp. 98-102
56. IWASAKI T; HAMANO T; AIZAWA K; KOBAYASHI K; KAKISHITA E
    INCREASED SERUM CA125 LEVELS IN PLASMA-CELL DYSCRASIAS
    Acta haematologica
    
    T. Iwasaki et al., "INCREASED SERUM CA125 LEVELS IN PLASMA-CELL DYSCRASIAS", Acta haematologica, 98(2), 1997, pp. 104-108
57. PAPADAKI H; KYRIAKOU D; FOUDOULAKIS A; MARKIDOU F; ALEXANDRAKIS M; ELIOPOULOS GD
    SERUM LEVELS OF SOLUBLE IL-6 RECEPTOR IN MULTIPLE MYELOMA AS INDICATOR OF DISEASE-ACTIVITY
    Acta haematologica
    
    H. Papadaki et al., "SERUM LEVELS OF SOLUBLE IL-6 RECEPTOR IN MULTIPLE MYELOMA AS INDICATOR OF DISEASE-ACTIVITY", Acta haematologica, 97(4), 1997, pp. 191-195
58. HATA H; MATSUZAKI H; TAKEYA M; TAKATSUKI K
    FAS APO-1 (CD95)-MEDIATED AND CD95-INDEPENDENT APOPTOSIS OF MALIGNANTPLASMA-CELLS/
    Leukemia & lymphoma
    
    H. Hata et al., "FAS APO-1 (CD95)-MEDIATED AND CD95-INDEPENDENT APOPTOSIS OF MALIGNANTPLASMA-CELLS/", Leukemia & lymphoma, 24(1-2), 1996, pp. 35
59. TANIWAKI M; NISHIDA K; UEDA Y; TAKASHIMA T
    NONRANDOM CHROMOSOMAL REARRANGEMENTS AND THEIR IMPLICATIONS IN CLINICAL-FEATURES AND OUTCOME OF MULTIPLE-MYELOMA AND PLASMA-CELL LEUKEMIA
    Leukemia & lymphoma
    
    M. Taniwaki et al., "NONRANDOM CHROMOSOMAL REARRANGEMENTS AND THEIR IMPLICATIONS IN CLINICAL-FEATURES AND OUTCOME OF MULTIPLE-MYELOMA AND PLASMA-CELL LEUKEMIA", Leukemia & lymphoma, 21(1-2), 1996, pp. 25
60. SAJEVA MR; GRECO MM; CASCAVILLA N; DARENA G; SCALZULLI P; MELILLO L; MINERVINI MM; BONINI A; DIMAURO L; CAROTENUTO M; MUSTO P
    EFFECTIVE AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION IN PLASMA-CELL LEUKEMIA FOLLOWED BY T-LARGE GRANULAR LYMPHOCYTE EXPANSION -A CASE-REPORT
    Bone marrow transplantation
    
    M.R. Sajeva et al., "EFFECTIVE AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION IN PLASMA-CELL LEUKEMIA FOLLOWED BY T-LARGE GRANULAR LYMPHOCYTE EXPANSION -A CASE-REPORT", Bone marrow transplantation, 18(1), 1996, pp. 225-227
61. HAROUSSEAU JL; KLEIN B
    THE USE OF INTERFERON-ALPHA IN MULTIPLE-M YELOMA
    La Revue de medecine interne
    
    J.L. Harousseau e B. Klein, "THE USE OF INTERFERON-ALPHA IN MULTIPLE-M YELOMA", La Revue de medecine interne, 17(6), 1996, pp. 488-495
62. CUNEO A; BALSAMO R; ROBERTI MG; BARDI A; PIVA N; BALBONI M; BIGONI R; RIGOLIN GM; CASTOLDI G
    INTERLEUKIN-3 PLUS INTERLEUKIN-6 MAY IMPROVE CHROMOSOMAL ANALYSIS OF MULTIPLE-MYELOMA - CYTOLOGIC AND CYTOGENETIC EVIDENCE IN 34 PATIENTS
    Cancer genetics and cytogenetics
    
    A. Cuneo et al., "INTERLEUKIN-3 PLUS INTERLEUKIN-6 MAY IMPROVE CHROMOSOMAL ANALYSIS OF MULTIPLE-MYELOMA - CYTOLOGIC AND CYTOGENETIC EVIDENCE IN 34 PATIENTS", Cancer genetics and cytogenetics, 90(2), 1996, pp. 171-175
63. VANDENAKKER TW; RADL J; FRANKENPOSTMA E; HAGEMEIJER A
    CYTOGENETIC FINDINGS IN MOUSE MULTIPLE-MYELOMA AND WALDENSTROMS MACROGLOBULINEMIA
    Cancer genetics and cytogenetics
    
    T.W. Vandenakker et al., "CYTOGENETIC FINDINGS IN MOUSE MULTIPLE-MYELOMA AND WALDENSTROMS MACROGLOBULINEMIA", Cancer genetics and cytogenetics, 86(2), 1996, pp. 156-161
64. SOLE F; WOESSNER S; ACIN P; PEREZLOSADA A; FLORENSA L; BESSES C; SANSSABRAFEN J
    CYTOGENETIC ABNORMALITIES IN 13 PATIENTS WITH MULTIPLE-MYELOMA
    Cancer genetics and cytogenetics
    
    F. Sole et al., "CYTOGENETIC ABNORMALITIES IN 13 PATIENTS WITH MULTIPLE-MYELOMA", Cancer genetics and cytogenetics, 86(2), 1996, pp. 162-164
65. BERGSAGEL PL; CHESI M; NARDINI E; BRENTS LA; KIRBY SL; KUEHL WM
    PROMISCUOUS TRANSLOCATIONS INTO IMMUNOGLOBULIN HEAVY-CHAIN SWITCH REGIONS IN MULTIPLE-MYELOMA
    Proceedings of the National Academy of Sciences of the United Statesof America
    
    P.L. Bergsagel et al., "PROMISCUOUS TRANSLOCATIONS INTO IMMUNOGLOBULIN HEAVY-CHAIN SWITCH REGIONS IN MULTIPLE-MYELOMA", Proceedings of the National Academy of Sciences of the United Statesof America, 93(24), 1996, pp. 13931-13936
66. PEEST D; BLADE J; HAROUSSEAU JL; KLEIN B; OSTERBORG A; SANMIGUEL JF
    CYTOKINE THERAPY IN MULTIPLE-MYELOMA
    British Journal of Haematology
    
    D. Peest et al., "CYTOKINE THERAPY IN MULTIPLE-MYELOMA", British Journal of Haematology, 94(3), 1996, pp. 425-432
67. ZANDECKI M
    MULTIPLE-MYELOMA - ALMOST-ALL PATIENTS ARE CYTOGENETICALLY ABNORMAL
    British Journal of Haematology
    
    M. Zandecki, "MULTIPLE-MYELOMA - ALMOST-ALL PATIENTS ARE CYTOGENETICALLY ABNORMAL", British Journal of Haematology, 94(2), 1996, pp. 217-227
68. OHSAKA A; SATO N; IMAI Y; HIRAI S; OKA Y; KIKUCHI M; TAKAHASHI A
    MULTIPLE GASTRIC INVOLVEMENT BY MYELOID ANTIGEN CD13-POSITIVE NONSECRETORY PLASMA-CELL LEUKEMIA
    British Journal of Haematology
    
    A. Ohsaka et al., "MULTIPLE GASTRIC INVOLVEMENT BY MYELOID ANTIGEN CD13-POSITIVE NONSECRETORY PLASMA-CELL LEUKEMIA", British Journal of Haematology, 92(1), 1996, pp. 134-136
69. TABERNERO D; SANMIGUEL JF; GARCIASANZ R; NAJERA L; GARCIAISIDORO M; PEREZSIMON JA; GONZALEZ M; WIEGANT J; RAAP AK; ORFAO A
    INCIDENCE OF CHROMOSOME NUMERICAL CHANGES IN MULTIPLE-MYELOMA - FLUORESCENCE IN-SITU HYBRIDIZATION ANALYSIS USING 15 CHROMOSOME-SPECIFIC PROBES
    The American journal of pathology
    
    D. Tabernero et al., "INCIDENCE OF CHROMOSOME NUMERICAL CHANGES IN MULTIPLE-MYELOMA - FLUORESCENCE IN-SITU HYBRIDIZATION ANALYSIS USING 15 CHROMOSOME-SPECIFIC PROBES", The American journal of pathology, 149(1), 1996, pp. 153-161
70. KYLE RA
    PROGNOSTIC FACTORS IN MULTIPLE-MYELOMA
    Stem cells
    
    R.A. Kyle, "PROGNOSTIC FACTORS IN MULTIPLE-MYELOMA", Stem cells, 13, 1995, pp. 56-63
71. RICHTER J; SWEDIN A; OLOFSSON T; JOHANSSON B; AKERMAN M; WINQVIST I
    AGGRESSIVE COURSE OF PRIMARY PLASMA-CELL LEUKEMIA WITH UNUSUAL MORPHOLOGICAL AND CYTOGENETIC FEATURES
    Annals of hematology
    
    J. Richter et al., "AGGRESSIVE COURSE OF PRIMARY PLASMA-CELL LEUKEMIA WITH UNUSUAL MORPHOLOGICAL AND CYTOGENETIC FEATURES", Annals of hematology, 71(6), 1995, pp. 307-310
72. KUO MC; SHIH LY
    PRIMARY PLASMA-CELL LEUKEMIA WITH EXTENSIVE DENSE OSTEOSCLEROSIS - COMPLETE REMISSION FOLLOWING COMBINATION CHEMOTHERAPY
    Annals of hematology
    
    M.C. Kuo e L.Y. Shih, "PRIMARY PLASMA-CELL LEUKEMIA WITH EXTENSIVE DENSE OSTEOSCLEROSIS - COMPLETE REMISSION FOLLOWING COMBINATION CHEMOTHERAPY", Annals of hematology, 71(3), 1995, pp. 147-151
73. MUGNERET F; SIDANER I; FAVRE B; MANONE L; MAYNADIE M; CAILLOT D; SOLARY E
    DER(16)T(1-16)(Q10-P10) IN MULTIPLE-MYELOMA - A NEW NONRANDOM ABNORMALITY THAT IS FREQUENTLY ASSOCIATED WITH BURKITTS-TYPE TRANSLOCATIONS
    Leukemia
    
    F. Mugneret et al., "DER(16)T(1-16)(Q10-P10) IN MULTIPLE-MYELOMA - A NEW NONRANDOM ABNORMALITY THAT IS FREQUENTLY ASSOCIATED WITH BURKITTS-TYPE TRANSLOCATIONS", Leukemia, 9(2), 1995, pp. 277-281
74. FELETTI A; TARTAGLIA M; CAMPANINI B; FERRARI G; MASINA M
    ISOLATED OCULOMOTOR PALSY AS INITIAL MANI FESTATION OF MULTIPLE-MYELOMA
    Journal francais d'ophtalmologie
    
    A. Feletti et al., "ISOLATED OCULOMOTOR PALSY AS INITIAL MANI FESTATION OF MULTIPLE-MYELOMA", Journal francais d'ophtalmologie, 18(12), 1995, pp. 771-776
75. ANKATHIL R; MADHAVAN J; GANGADHARAN VP; PILLAI GR; NAIR MK
    NONRANDOM KARYOTYPE ABNORMALITIES IN 36 MULTIPLE-MYELOMA PATIENTS
    Cancer genetics and cytogenetics
    
    R. Ankathil et al., "NONRANDOM KARYOTYPE ABNORMALITIES IN 36 MULTIPLE-MYELOMA PATIENTS", Cancer genetics and cytogenetics, 83(1), 1995, pp. 71-74
76. DRACH J; SCHUSTER J; NOWOTNY H; ANGERLER J; ROSENTHAL F; FIEGL M; ROTHERMUNDT C; GSUR A; JAGER U; HEINZ R; LECHNER K; LUDWIG H; HUBER H
    MULTIPLE-MYELOMA - HIGH-INCIDENCE OF CHROMOSOMAL ANEUPLOIDY AS DETECTED BY INTERPHASE FLUORESCENCE IN-SITU HYBRIDIZATION
    Cancer research
    
    J. Drach et al., "MULTIPLE-MYELOMA - HIGH-INCIDENCE OF CHROMOSOMAL ANEUPLOIDY AS DETECTED BY INTERPHASE FLUORESCENCE IN-SITU HYBRIDIZATION", Cancer research, 55(17), 1995, pp. 3854-3859
77. HERNANDEZ JA; LAND KJ; MCKENNA RW
    LEUKEMIAS, MYELOMA, AND OTHER LYMPHORETICULAR NEOPLASMS
    Cancer
    
    J.A. Hernandez et al., "LEUKEMIAS, MYELOMA, AND OTHER LYMPHORETICULAR NEOPLASMS", Cancer, 75(1), 1995, pp. 381-394
78. OHTANI K; NINOMIYA H; HASEGAWA Y; KOBAYASHI T; KOJIMA H
    CLINICAL-SIGNIFICANCE OF ELEVATED SOLUBLE INTERLEUKIN-6 RECEPTOR LEVELS IN THE SERA OF PATIENTS WITH PLASMA-CELL DYSCRASIAS
    British Journal of Haematology
    
    K. Ohtani et al., "CLINICAL-SIGNIFICANCE OF ELEVATED SOLUBLE INTERLEUKIN-6 RECEPTOR LEVELS IN THE SERA OF PATIENTS WITH PLASMA-CELL DYSCRASIAS", British Journal of Haematology, 91(1), 1995, pp. 116-120
79. SMADJA NV; LOUVET C; ISNARD F; DUTEL JL; GRANGE M; VARETTE C; KRULIK M
    CYTOGENETIC STUDY IN MULTIPLE-MYELOMA AT DIAGNOSIS - COMPARISON OF 2 TECHNIQUES
    British Journal of Haematology
    
    N.V. Smadja et al., "CYTOGENETIC STUDY IN MULTIPLE-MYELOMA AT DIAGNOSIS - COMPARISON OF 2 TECHNIQUES", British Journal of Haematology, 90(3), 1995, pp. 619-624
80. YEH KH; LIN MT; TANG JL; YANG CH; TSAY W; CHEN YC
    LONG-TERM DISEASE-FREE SURVIVAL AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN A PRIMARY PLASMA-CELL LEUKEMIA - DETECTION OF MINIMAL RESIDUAL DISEASE IN THE TRANSPLANT MARROW BY 3RD-COMPLEMENTARITY-DETERMINING REGION-SPECIFIC PROBES
    British Journal of Haematology
    
    K.H. Yeh et al., "LONG-TERM DISEASE-FREE SURVIVAL AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN A PRIMARY PLASMA-CELL LEUKEMIA - DETECTION OF MINIMAL RESIDUAL DISEASE IN THE TRANSPLANT MARROW BY 3RD-COMPLEMENTARITY-DETERMINING REGION-SPECIFIC PROBES", British Journal of Haematology, 89(4), 1995, pp. 914-916
81. LAI JL; ZANDECKI M; MARY JY; BERNARDI F; IZYDORCZYK V; FLACTIF M; MOREL P; JOUET JP; BAUTERS F; FACON T
    IMPROVED CYTOGENETICS IN MULTIPLE-MYELOMA - A STUDY OF 151 PATIENTS INCLUDING 117 PATIENTS AT DIAGNOSIS
    Blood
    
    J.L. Lai et al., "IMPROVED CYTOGENETICS IN MULTIPLE-MYELOMA - A STUDY OF 151 PATIENTS INCLUDING 117 PATIENTS AT DIAGNOSIS", Blood, 85(9), 1995, pp. 2490-2497
82. KOBAYASHI H; SAITO H; KITANO K; KIYOSAWA K; GAUN S; AOKI K; NARITA A; WATANABE M; UCHIMARU K; MOTOKURA T
    OVEREXPRESSION OF THE PRAD1 ONCOGENE IN A PATIENT WITH MULTIPLE-MYELOMA AND T(11-14)(Q13-Q32)
    Acta haematologica
    
    H. Kobayashi et al., "OVEREXPRESSION OF THE PRAD1 ONCOGENE IN A PATIENT WITH MULTIPLE-MYELOMA AND T(11-14)(Q13-Q32)", Acta haematologica, 94(4), 1995, pp. 199-203
83. CORRADINI P; LADETTO M; INGHIRAMI G; BOCCADORO M; PILERI A
    N-RAS AND K-RAS ONCOGENES IN PLASMA-CELL DYSCRASIAS
    Leukemia & lymphoma
    
    P. Corradini et al., "N-RAS AND K-RAS ONCOGENES IN PLASMA-CELL DYSCRASIAS", Leukemia & lymphoma, 15(1-2), 1994, pp. 17-20
84. MURAYAMA T; MATSUI T; HAYASHI Y; TANIGUCHI T; ITO M; NATAZUKA T; IMOTO S; IWATA N; ISOBE T; ITO H; CHIHARA K
    PLASMA-CELL LEUKEMIA WITH MYELOFIBROSIS
    Annals of hematology
    
    T. Murayama et al., "PLASMA-CELL LEUKEMIA WITH MYELOFIBROSIS", Annals of hematology, 69(3), 1994, pp. 151-152
85. YAMAGATA N; SHIMAZAKI C; GOTO H; HIRATA T; ASHIHARA E; OKU N; INABA T; FUJITA N; NAKAGAWA M
    IGE PLASMA-CELL LEUKEMIA SUCCESSFULLY TREATED WITH COMBINATION VAD (VINCRISTINE, DOXORUBICIN, DEXAMETHASONE) AND MP (MELPHALAN, PREDNISOLONE) FOLLOWED BY INTERFERON-ALPHA
    American journal of hematology
    
    N. Yamagata et al., "IGE PLASMA-CELL LEUKEMIA SUCCESSFULLY TREATED WITH COMBINATION VAD (VINCRISTINE, DOXORUBICIN, DEXAMETHASONE) AND MP (MELPHALAN, PREDNISOLONE) FOLLOWED BY INTERFERON-ALPHA", American journal of hematology, 45(3), 1994, pp. 262-264
86. LUST JA
    ROLE OF CYTOKINES IN THE PATHOGENESIS OF MONOCLONAL GAMMOPATHIES
    Mayo Clinic proceedings
    
    J.A. Lust, "ROLE OF CYTOKINES IN THE PATHOGENESIS OF MONOCLONAL GAMMOPATHIES", Mayo Clinic proceedings, 69(7), 1994, pp. 691-697
87. CHILD JA
    EVOLVING STRATEGIES FOR THE TREATMENT OF MYELOMATOSIS
    British Journal of Haematology
    
    J.A. Child, "EVOLVING STRATEGIES FOR THE TREATMENT OF MYELOMATOSIS", British Journal of Haematology, 88(4), 1994, pp. 672-678
88. DIMOPOULOS MA; PALUMBO A; DELASALLE KB; ALEXANIAN R
    PRIMARY PLASMA-CELL LEUKEMIA
    British Journal of Haematology
    
    M.A. Dimopoulos et al., "PRIMARY PLASMA-CELL LEUKEMIA", British Journal of Haematology, 88(4), 1994, pp. 754-759
89. SAWAMURA M; MURAYAMA K; TOKIZAWA S; MATSUSHIMA T; TAMURA J; MURAKAMI H; NARUSE T; TSUCHIYA J
    CHANGE OF PARAPROTEIN FROM IGG LAMBDA TO LAMBDA CHAIN IN MYELOMA
    Annals of hematology
    
    M. Sawamura et al., "CHANGE OF PARAPROTEIN FROM IGG LAMBDA TO LAMBDA CHAIN IN MYELOMA", Annals of hematology, 66(4), 1993, pp. 215-216
90. ECLACHE V; LUSINA D; LEJEUNE F; CASASSUS P; SMADJA N; LORTHOLARY P
    PLASMA-CELL LEUKEMIA MIMICKING ACUTE MONOCYTIC LEUKEMIA IN THE COURSEOF MULTIPLE-MYELOMA
    Nouvelle revue francaise d'hematologie
    
    V. Eclache et al., "PLASMA-CELL LEUKEMIA MIMICKING ACUTE MONOCYTIC LEUKEMIA IN THE COURSEOF MULTIPLE-MYELOMA", Nouvelle revue francaise d'hematologie, 35(4), 1993, pp. 419-422
91. PORTIER M; ZHANG XG; URSULE E; LEES D; JOURDAN M; BATAILLE R; KLEIN B
    CYTOKINE GENE-EXPRESSION IN HUMAN MULTIPLE-MYELOMA
    British Journal of Haematology
    
    M. Portier et al., "CYTOKINE GENE-EXPRESSION IN HUMAN MULTIPLE-MYELOMA", British Journal of Haematology, 85(3), 1993, pp. 514-520